Chinese provinces hit hard by Covid are seeing a strain on critical care, health officials say

Chinese provinces hit hard by Covid are seeing a strain on critical care, health officials say


People wait outside a fever clinic at Tongren Hospital in Shanghai on Dec. 23, 2022, amid a local outbreak of Covid-19 infections.

Hector Retamal | Afp | Getty Images

BEIJING — Some Chinese provinces’ intensive care beds and resources are nearing capacity as Covid-19 infections soar, national health authorities said Tuesday.

“In provinces currently experiencing high demand for intensive care, they are nearing the critical threshold of available ICU beds and resources,” Jiao Yahui, director of the medical affairs department at China’s National Health Commission, said during a press conference. That’s according to a CNBC translation of the Mandarin remarks.

In such regions, Jiao said, “it is necessary to expand the availability of ICU beds and resources, or speed up turnover.”

Overall, Jiao claimed national availability of ICU beds was sufficient, at 12.8 per 100,000 people as of Dec. 25.

Early this month, mainland China abruptly ended many Covid controls. Infections have meanwhile surged, pressuring the country’s already stretched health system.

It is unclear at what scale Covid outbreaks have hit the country, with few official figures on recent infections and deaths. China’s National Health Commission on Sunday stopped sharing daily figures after a halt in mandatory virus testing.

China's reopening is good news for the long term but bad news for the short term, consultancy says

Some local governments have disclosed details on the regional situation.

Zhejiang province — bordering Shanghai — said Sunday that daily Covid infections in the region have surpassed 1 million, and will likely double to a peak of 2 million a day around New Year’s. The province has a population of about 65.4 million.

In the capital city of Beijing — one of the earliest to see a Covid wave — the share of severe cases and elderly patients has increased at fever clinics, according to an official report Saturday. It cited a director at a local hospital as saying the share of visits by the elderly had climbed from below 20% to nearly 50%.

Read more about China from CNBC Pro

China’s health authorities were speaking Tuesday at a briefing on the country’s new Covid measures, released late Monday. The policy changes included plans to scrap quarantine for inbound travelers starting Jan. 8.

“We view the new guidelines as a major step towards the full reopening, but caution on the increased challenges to China’s medical system in the near term,” Goldman Sachs analysts said in a note Tuesday.

“The frontloaded China reopening timetable adds conviction to our below-consensus forecast for Q4 GDP growth (+1.7% yoy) and above-consensus 2023 GDP forecast (+5.2% yoy),” the analysts said.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More